StoxSai Life Sciences vs Krishna Institute of Medical Sciences: share price & financials comparison
NSE: SAILIFE vs KIMS · Healthcare · as of 13 Nov 2026
Both prices rebased to 100 at the start of the selected period.
Sai Life Sciences vs Krishna Institute of Medical Sciences at a glance
Sai Life Sciences (SAILIFE) has a market capitalisation of ₹40,972 Cr, against ₹30,645 Cr for Krishna Institute of Medical Sciences (KIMS). Over the past year Sai Life Sciences has returned +108.9%, compared with +1.8% for Krishna Institute of Medical Sciences. On valuation, Krishna Institute of Medical Sciences trades at a lower P/E of 144.3 versus 202.3. Sai Life Sciences earns a higher return on equity (7.5% vs 5.4%). Sai Life Sciences comes out ahead on size, profitability, financial health, momentum and technicals. Krishna Institute of Medical Sciences comes out ahead on valuation and growth. Across the scored metrics below, Sai Life Sciences leads on 9 and Krishna Institute of Medical Sciences on 3. On StoxGud's 10-point checklist, Sai Life Sciences scores 6/10 and Krishna Institute of Medical Sciences scores 4/10.
| Metric | Sai Life Sciences | Krishna Institute of Medical Sciences |
|---|---|---|
| Size | ||
| Market cap | ₹40,972 Cr | ₹30,645 Cr |
| Revenue (latest FY) | ₹2,192 Cr | ₹3,905 Cr |
| Net profit (latest FY) | ₹349 Cr | ₹241 Cr |
| Valuation | ||
| P/E | 202.3 | 144.3 |
| P/B | 15.24 | 7.79 |
| Dividend yield | — | 0.68% |
| Profitability | ||
| Return on equity | 7.5% | 5.4% |
| Net profit margin | 8.5% | 4.6% |
| Operating margin | 29.5% | 19.3% |
| Growth | ||
| Revenue growth (YoY) | +22.5% | +39.9% |
| Net profit growth (YoY) | — | +11.8% |
| Revenue CAGR (multi-year) | — | +24.0% |
| Financial health | ||
| Debt to equity | 0.17 | 0.90 |
| Momentum | ||
| 1-month return | +31.9% | +2.8% |
| 1-year return | +108.9% | +1.8% |
| 3-year CAGR | — | +25.0% |
| 5-year CAGR | — | +24.9% |
| Distance from 52W high | +0.0% | -14.2% |
| Technicals | ||
| RSI (14) | 93 | 80 |
| Price vs 200-day avg | +56.3% | -0.1% |
Highlighted cells lead on that metric. Market cap, revenue and RSI are shown for context and not scored.
10-point checklist side by side
| Check | Sai Life Sciences | Krishna Institute of Medical Sciences |
|---|---|---|
| Price above 50-day average | ✓ | ✗ |
| Price above 200-day average | ✓ | ✗ |
| 50-day average above 200-day (uptrend) | ✓ | ✓ |
| RSI in healthy 40–70 zone | ✗ | ✗ |
| Positive 1-year return | ✓ | ✓ |
| Return on equity above 15% | ✗ | ✗ |
| Debt to equity below 1 | ✓ | ✓ |
| Revenue growing year on year | ✓ | ✓ |
| Net profit margin above 10% | ✗ | ✗ |
| P/E below industry median | ✗ | ✗ |
| Score | 6/10 | 4/10 |
A rules-based screen for education only — not a buy or sell recommendation.
FAQs
Which is bigger, Sai Life Sciences or Krishna Institute of Medical Sciences?
Sai Life Sciences has a market cap of ₹40,972 Cr and Krishna Institute of Medical Sciences has a market cap of ₹30,645 Cr as of 13 Nov 2026.
Which has a lower P/E, Sai Life Sciences or Krishna Institute of Medical Sciences?
Krishna Institute of Medical Sciences has the lower P/E: Sai Life Sciences trades at 202.3 and Krishna Institute of Medical Sciences at 144.3.
Which gave better returns in the last year, Sai Life Sciences or Krishna Institute of Medical Sciences?
Sai Life Sciences did better: Sai Life Sciences returned +108.9% and Krishna Institute of Medical Sciences returned +1.8% over one year.
What is the difference between Sai Life Sciences and Krishna Institute of Medical Sciences?
Both are NSE-listed companies in Healthcare. Sai Life Sciences is about 1.3 times the size of Krishna Institute of Medical Sciences by market cap. In the latest financial year Sai Life Sciences reported revenue of ₹2,192 Cr and Krishna Institute of Medical Sciences ₹3,905 Cr. Operating margin is 29.5% for Sai Life Sciences and 19.3% for Krishna Institute of Medical Sciences. Debt to equity is 0.17 for Sai Life Sciences and 0.90 for Krishna Institute of Medical Sciences.
Which is better, Sai Life Sciences or Krishna Institute of Medical Sciences?
It depends on what you are looking for, and StoxGud does not recommend either stock. On the metrics compared above, Sai Life Sciences leads on 9 and Krishna Institute of Medical Sciences on 3. Sai Life Sciences is ahead on size, profitability, financial health, momentum and technicals. Krishna Institute of Medical Sciences is ahead on valuation and growth. On StoxGud's rules-based checklist Sai Life Sciences scores 6/10 and Krishna Institute of Medical Sciences scores 4/10. This is information, not advice: consult a SEBI-registered adviser before investing.